Clinical Trials Browser

OTHER × durvalumab × Tumor-Agnostic × Clear all

NCT02029001 2025-08-07

MOST plus

Phase 2 Recruiting

Neoplasm Metastasis

NCT06031233 2025-05-21

MINUTE

Phase 4 Recruiting

Neoplasms

NCT03406650 2025-05-04

SAKK 06/17

Phase 2 Completed

Neoplasms

NCT03094286 2024-06-24

Durvalumab in HIV-1 Patients With Solid Tumors

Phase 2 Completed

20 enrolled 36 charts

Neoplasms